文献速递糖尿病肥胖与代谢综合征

血浆支链氨基酸水平升高与2型糖尿病相关代谢紊乱相关

Elevated Plasma Branched-Chain Amino Acid Levels Correlate With Type 2 Diabetes-Related Metabolic Disturbances.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

T2DM患者总支链氨基酸(BCAA)水平高于CON,且与肌肉线粒体氧化能力负相关(r=-0.44,P<.001);T2DM患者基础状态全身亮氨酸氧化率低于CON(0.202±0.049 vs 0.275±0.043 μmol kg-1 min-1,P<.05)。

要点

  • T2DM患者血浆BCAA水平升高,且与肌肉线粒体氧化能力负相关。
  • T2DM患者基础状态全身亮氨酸氧化率低于对照。
  • 高胰岛素输注期间亮氨酸氧化率有降低趋势(P=.075)。

核心结论

  • T2DM患者全身亮氨酸氧化率降低,支持血浆BCAA水平升高至少部分源于线粒体氧化能力低下。

研究设计与样本

  • 离体肌肉线粒体氧化能力用高分辨率呼吸测定法检测透化肌纤维。
  • 亚组5例T2DM患者和5例CON接受高胰岛素-正葡萄糖钳夹联合1-13C亮氨酸输注以测定全身亮氨酸氧化。

主要发现

  • T2DM患者总BCAA水平高于CON,但FDR与CON无差异。
  • 总BCAA水平与肌肉线粒体氧化能力负相关(r=-0.44,P<.001)。
  • 基础状态全身亮氨酸氧化率T2DM低于CON(0.202±0.049 vs 0.275±0.043 μmol kg-1 min-1,P<.05)。
  • 高胰岛素输注期间全身亮氨酸氧化率T2DM有低于CON趋势(0.326±0.024 vs 0.382±0.013 μmol kg-1 min-1,P=.075)。

临床怎么用

  • 血浆BCAA升高可能反映T2DM患者肌肉线粒体氧化能力受损。
  • 改善线粒体氧化能力或可成为降低BCAA水平的潜在干预方向。

局限性

  • 研究为观察性设计,无法确定因果关系。
  • 亮氨酸氧化仅在5例T2DM和5例CON亚组中测定,样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Patients with type 2 diabetes mellitus (T2DM) have elevated plasma branched-chain amino acid (BCAA) levels. The underlying cause, however, is not known. Low mitochondrial oxidation of BCAA levels could contribute to higher plasma BCAA levels. OBJECTIVE: We aimed to investigate ex vivo muscle mitochondrial oxidative capacity and in vivo BCAA oxidation measured by whole-body leucine oxidation rates in patients with T2DM, first-degree relatives (FDRs), and control participants (CONs) with overweight or obesity. DESIGN AND SETTING: An observational, community-based study was conducted. PARTICIPANTS: Fifteen patients with T2DM, 13 FDR, and 17 CONs were included (age, 40-70 years; body mass index, 27-35 kg/m2). MAIN OUTCOME MEASURES: High-resolution respirometry was used to examine ex vivo mitochondrial oxidative capacity in permeabilized muscle fibers. A subgroup of 5 T2DM patients and 5 CONs underwent hyperinsulinemic-euglycemic clamps combined with 1-13C leucine-infusion to determine whole-body leucine oxidation. RESULTS: Total BCAA levels were higher in patients with T2DM compared to CONs, but not in FDRs, and correlated negatively with muscle mitochondrial oxidative capacity (r = -0.44, P < .001). Consistently, whole-body leucine oxidation rate was lower in patients with T2DM vs CON under basal conditions (0.202 ± 0.049 vs 0.275 ± 0.043 μmol kg-1 min-1, P < .05) and tended to be lower during high insulin infusion (0.326 ± 0.024 vs 0.382 ± 0.013 μmol kg-1 min-1, P = .075). CONCLUSIONS: In patients with T2DM, a compromised whole-body leucine oxidation rate supports our hypothesis that higher plasma BCAA levels may originate at least partly from a low mitochondrial oxidative capacity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Vanweert F, de Ligt M, Hoeks J, et al. Elevated Plasma Branched-Chain Amino Acid Levels Correlate With Type 2 Diabetes-Related Metabolic Disturbances. J Clin Endocrinol Metab. 2021. PMID: 33079174. doi:10.1210/clinem/dgaa751

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。